Directory
>
Andy Ramelmeier
Andy Ramelmeier
Chief Technology Officer | Adverum Biotechnologies
San Francisco, California, United States
Andy Ramelmeier
Summary
Andy Ramelmeier is a seasoned executive in the biopharmaceutical industry, with over 30 years of experience in biochemistry and biotechnology. Currently serving as the Chief Technology Officer at Adverum Biotechnologies, he has a proven track record in the development and manufacturing of biologics, including monoclonal antibodies and gene therapy products. His leadership has been pivotal in overseeing the construction of multiple biologics production facilities, showcasing his expertise in strategic planning and operational excellence. Andy is recognized for his innovative approach to manufacturing processes, emphasizing quality and efficiency. His commitment to patient-centered outcomes drives his work, as he balances technical management with company growth. He has also been a sought-after speaker at industry conferences and academic institutions, reflecting his influence and thought leadership in the field. With a strong educational background in chemical engineering, he continues to contribute significantly to advancements in biopharmaceutical manufacturing.
Andy Ramelmeier
Work Experience
Chief Technology Officer at
Adverum Biotechnologies
August 2023 - Present
EVP Technical Operations at
Sangamo Therapeutics, Inc.
September 2019 - July 2023
SVP Technical Operations at
Sangamo Therapeutics, Inc.
January 2018 - September 2019
SVP, Technical Operations Biologics at
Portola Pharmaceuticals
January 2014 - January 2017
VP, Global Manufacturing and Facilities at
BioMarin Pharmaceutical Inc.
January 2011 - January 2014
VP Manufacturing, Process Sciences and Facilities at
BioMarin Pharmaceutical Inc.
January 2006 - January 2011
VP. Process Sciences at
Johnson & Johnson
January 2005 - January 2006
Executive Director at
Centocor R And D
January 2001 - January 2005
Senior Research Fellow at
Merck
January 1991 - January 2001
Andy Ramelmeier
Education
Alexander von Humboldt Foundation, Post-Doctoral Fellow
January 1990 - January 1991
Institute of Enzyme Technology, Julich Germany, Post-Doctorate Research
January 1990 - January 1991
University of California, Berkeley, Phd
January 1984 - January 1989
January 1980 - January 1984
Frequently Asked Questions about Andy Ramelmeier
What is Andy Ramelmeier email address?
Andy Ramelmeier's primary email address is ***********@sangamo.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Andy Ramelmeier work for?
Andy Ramelmeier is a Chief Technology Officer at Adverum Biotechnologies, a company specializing in Commercial physical research.
Where Andy Ramelmeier graduated from?
Andy Ramelmeier holds a degree in from Alexander von Humboldt Foundation.
How can I directly contact Andy Ramelmeier?
To contact Andy Ramelmeier directly, you can use the email address ***********@sangamo.com. Complete contact information is available upon registration with Muraena.
Who is Andy Ramelmeier?
Andy Ramelmeier is a seasoned executive in the biopharmaceutical industry, with over 30 years of experience in biochemistry and biotechnology. Currently serving as the Chief Technology Officer at Adverum Biotechnologies, he has a proven track record in the development and manufacturing of biologics, including monoclonal antibodies and gene therapy products. His leadership has been pivotal in overseeing the construction of multiple biologics production facilities, showcasing his expertise in strategic planning and operational excellence. Andy is recognized for his innovative approach to manufacturing processes, emphasizing quality and efficiency. His commitment to patient-centered outcomes drives his work, as he balances technical management with company growth. He has also been a sought-after speaker at industry conferences and academic institutions, reflecting his influence and thought leadership in the field. With a strong educational background in chemical engineering, he continues to contribute significantly to advancements in biopharmaceutical manufacturing.
Andy`s contact details
***********@sangamo.com
***********@adverum.com
Colleagues
Executive Director, Scientific Program Management
Chief Operating Officer
Vice President, Clinical Development and Access Strategy
Executive Director, Regulatory Affairs
Executive Director, IT
Executive Director, Quality Control
Vice President, Legal
Chief Development Operations Officer
Chief People Officer
Executive Director; CMC Lead